Skip to main content
SpringerLink
Log in

Circulating periostin in patients with nonalcoholic fatty liver disease

  • Research Letter
  • Published:
Endocrine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. S.A. Polyzos, J. Kountouras, C. Zavos, Nonalcoholic fatty liver disease: The pathogenetic roles of insulin resistance and adipocytokines. Curr. Mol. Med. 72, 299–314 (2009)

    Article  Google Scholar 

  2. S.A. Polyzos, C.S. Mantzoros, Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease. Metabolism 63, 161–167 (2014)

    Article  CAS  Google Scholar 

  3. A.Y. Liu, H. Zheng, G. Ouyang, Periostin, a multifunctional matricellular protein in inflammatory and tumor microenvironments. Matrix. Biol. 37, 150–156 (2014)

    Article  Google Scholar 

  4. S.A. Polyzos, A.D. Anastasilakis, Periostin on the road to nonalcoholic fatty liver disease. Endocrine 51, 4–6 (2016)

    Article  CAS  Google Scholar 

  5. J.Z. Zhu, H.T. Zhu, Y.N. Dai, C.X. Li, Z.Y. Fang, D.J. Zhao, X.Y. Wan, Y.M. Wang, F. Wang, C.H. Yu, Y.M. Li, Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case-control study. Endocrine 51, 91–100 (2016)

    Article  CAS  Google Scholar 

  6. S. Polyzos, J. Kountouras, A. Papatheodorou, E. Katsiki, K. Patsiaoura, E. Zafeiriadou, C. Zavos, E. Papadopoulou, E. Terpos, Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease—Introduction of CHA index. Ann. Hepatol. 12, 749–757 (2013)

    Article  CAS  Google Scholar 

  7. D.E. Kleiner, E.M. Brunt, N.M. Van, C. Behling, M.J. Contos, O.W. Cummings, L.D. Ferrell, Y.C. Liu, M.S. Torbenson, A. Unalp-Arida, M. Yeh, A.J. McCullough, A.J. Sanyal, Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313–1321 (2005)

    Article  Google Scholar 

  8. S.A. Polyzos, A.D. Anastasilakis, J. Kountouras, P. Makras, A. Papatheodorou, P. Kokkoris, G.T. Sakellariou, E. Terpos, Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease. J. Bone. Miner. Metab. 34, 447–456 (2016)

    Article  CAS  Google Scholar 

  9. T. Wu, S. Wu, G. Ouyang, Periostin: A new extracellular regulator of obesity-induced hepatosteatosis. Cell Metab. 20, 562–564 (2014)

    Article  CAS  Google Scholar 

  10. Y. Li, S. Wu, S. Xiong, G. Ouyang, Deficiency of periostin protects mice against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis. J. Hepatol. 62, 495–497 (2015)

    Article  CAS  Google Scholar 

  11. Y. Huang, W. Liu, H. Xiao, A. Maitikabili, Q. Lin, T. Wu, Z. Huang, F. Liu, Q. Luo, G. Ouyang, Matricellular protein periostin contributes to hepatic inflammation and fibrosis. Am. J. Pathol. 185, 786–797 (2015)

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors feel grateful to Dr. Efthymia Zafeiriadou (experienced radiologist), who performed the liver biopsies under computed tomography-guidance, and to Dr. Kalliopi Patsiaoura and Dr. Evangelia Katsiki (experienced pathologists), who interpreted the histological specimens.

Funding

No funding sources or other support for this study.

Author information

Authors and Affiliations

  1. Department of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

    Stergios A. Polyzos & Jannis Kountouras

  2. Department of Endocrinology, 424 General Military Hospital, Thessaloniki, Greece

    Athanasios D. Anastasilakis

  3. Department of Medical Research, 251 Hellenic Air Force & VA General Hospital, Athens, Greece

    Athanasios Papatheodorou & Panagiotis Kokkoris

  4. Department of Clinical Therapeutics, University of Athens, School of Medicine, Athens, Greece

    Evangelos Terpos

Authors
  1. Stergios A. Polyzos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jannis Kountouras
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Athanasios D. Anastasilakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Athanasios Papatheodorou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Panagiotis Kokkoris
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Evangelos Terpos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stergios A. Polyzos.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Polyzos, S.A., Kountouras, J., Anastasilakis, A.D. et al. Circulating periostin in patients with nonalcoholic fatty liver disease. Endocrine 56, 438–441 (2017). https://doi.org/10.1007/s12020-016-1144-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-016-1144-x

Search

Navigation